mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.006 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.007 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.007 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.007 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |